- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.04. | PaxMedica, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 07.03. | PaxMedica, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 06.02. | PaxMedica, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.01. | PaxMedica, Inc.: PaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other Conditions | 172 | ACCESS Newswire | BOSTON, MA / ACCESSWIRE / January 14, 2025 / PaxMedica, Inc. (OTC PINK:PXMD), a clinical-stage biopharmaceutical company dedicated to advancing treatments for neurological disorders, is pleased to announce... ► Artikel lesen | |
| 03.09.24 | PaxMedica, Inc.: PaxMedica Secures Immediate Exercise of Warrants | 218 | ACCESS Newswire | TARRYTOWN, NY / ACCESSWIRE / September 3, 2024 / PaxMedica, Inc. (OTC PINK:PXMD), a clinical-stage biopharmaceutical company dedicated to advancing treatments for neurological disorders, today announced... ► Artikel lesen | |
| PAXMEDICA Aktie jetzt für 0€ handeln | |||||
| 27.08.24 | PaxMedica, Inc.: PaxMedica Reports First Patient Treated with PAX-101 for Fatal African Sleeping Sickness Infection | 267 | ACCESS Newswire | Company provides update on regulatory progress towards US NDA submission TARRYTOWN, NY / ACCESSWIRE / August 27, 2024 / PaxMedica, Inc. (OTC PINK:PXMD), a clinical-stage biopharmaceutical company dedicated... ► Artikel lesen | |
| 15.05.24 | PaxMedica, Inc.: PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101 | 364 | GlobeNewswire (Europe) | TARRYTOWN, New York, May 15, 2024 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (the "Company" or "PaxMedica") (OTC:PXMD), a biopharmaceutical company dedicated to advancing treatments for neurological... ► Artikel lesen | |
| 23.04.24 | PaxMedica, Inc.: PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101 | 212 | GlobeNewswire (Europe) | TARRYTOWN, New York, April 23, 2024 (GLOBE NEWSWIRE) -- via IBN - PaxMedica Inc. (Nasdaq: PXMD) (the "Company"), a leading biopharmaceutical company dedicated to advancing treatments for neurological... ► Artikel lesen |
8 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|
PAXMEDICA INC gehört der Branche Biotechnologie an. Mit einer aktuellen Kursveränderung von +0,001 (+0,19 %) liegt der Kurs bei 0,690 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PAXMEDICA INC finden Sie auf Wallstreet Online.
